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PtII azido complexes [Pt(bpy)(N3)2] (1), [Pt(phen)(N3)2] (2) and trans-[Pt(N3)2(py)2] (3)
incorporating the bidentate diimine ligands 2,2'-bipyridine (bpy), 1,10-phenanthroline (phen) or the
monodentate pyridine (py) respectively, have been synthesised from their chlorido precursors and
characterised by x-ray crystallography; complex 3 shows significant deviation from square-planar
geometry (N3–Pt–N3 angle 146.7°) as a result of steric congestion at the Pt centre. The novel PtIV
complexes trans, cis-[Pt(bpy)(OAc)2(N3)2] (4), trans, cis-[Pt(phen)(OAc)2(N3)2] (5), trans, trans,
trans-[Pt(OAc)2(N3)2(py)2] (6), were obtained from 13 via oxidation with H2O2 in acetic acid
followed by reaction of the intermediate with acetic anhydride. Complexes 46 exhibit interesting
structural and photochemical properties that were studied by x-ray, NMR and UV-vis spectroscopy
and TDDFT. These PtIV complexes exhibit greater absorption at longer wavelengths ( = 9756
M1cm1 at 315 nm for 4;  = 796 M1cm1 at 352 nm for 5;  = 16900 M1cm-1 at 307 nm for 6, in
aqueous solution) than previously reported PtIV azide complexes, due to the presence of aromatic
amines, and 46 undergo photoactivation with both UVA (365 nm) and visible green light (514
nm). The UV-vis spectra of complexes 46 were calculated using TD-DFT; the nature of the
transitions contributing to the UV-vis bands provide insight into the mechanism of production of the
observed photoproducts. The UV-vis spectra of 13 were also simulated by computational methods
and comparison between PtII and PtIV electronic and structural properties allowed further elucidation
of the photochemistry of 46.
2Introduction
PtII pyridyl compounds are well-known to exhibit a rich photochemistry, which can be tuned
through peripheral modification of the ligands bound to the PtII centre.1,2 The low energy
spectroscopic absorption band in the visible region and long-lived excited states of these complexes
lead to a variety of applications, including their use in biosensors,3 light-emitting devices4 and dye-
sensitised solar cells.5 The biological properties of PtII amines have been extensively investigated,
with particular emphasis on potential antitumor activity following the success in the clinic of the PtII
drug cisplatin, cis-[Pt(NH3)2Cl2], and related complexes.6
PtIV complexes are much more inert to reaction than PtII species, and tuning their reactivity
to achieve selective reduction to PtII in vivo provides a strategy for reducing the side-reactions
associated with PtII antitumor drugs.7,8 Although reports of PtIV bipyridine complexes, for example,
have been largely structural,9 Lippert and co-workers have investigated the photoreduction of trans-
[Pt(bpy)(MeNH2)2(OH)2]Cl2; after irradiation for several days (dose not stated), free MeNH3+ was
detected, indicating that amine dissociation had occured.7,10
Photoactivation of metal complexes can be used for triggering specific interactions between
the metal complex and target macromolecules of biological relevance (such as DNA, RNA or
proteins).11 Upon irradiation, photoactivable metal complexes can undergo ligand dissociation from
the excited state, forming labile solvated species that are more reactive towards the target
macromolecule.12 Light activation offers the advantage of temporal- and spatial-control of the
active species in tissues, potentially reducing undesired secondary effects due to the toxicity of such
species. It is notable that several complexes of d8 metal ions with α-diimine ligands have been
reported to photosensitise the production of singlet oxygen (1O2)13–15 and so there is scope for the
use of photoactivatable metal complexes in photodynamic therapy16 and for virucidal
applications.17,18
The efficacy of photoactivatable metal complexes as potential anticancer agents depends
strongly on their excited-state properties. The relative energies of singlet and triplet excited states
influence the choice of the excitation wavelength, and determine the nature of the photoproducts,
their mechanism of formation and the yield of ligand photodissociation.19 Density functional theory
(DFT) and time-dependent DFT (TDDFT) are fundamental tools for rational design of metal-based
drugs with tunable properties, since they can provide a description of electronic structures and
excited states of metal complexes.20
Our recent approach has been to develop PtIV complexes which can be reduced to cytotoxic
PtII by photoactivation, selectively at a tumour site.21,22,23,24 For effective photochemotherapy of
3non-surface tumours it is desirable to activate complexes with relatively long wavelengths of light
since the penetration of light into tissue is wavelength-dependent.25 Furthermore, the use of visible
light is less likely to cause damage of biological tissue.25c,26 Current photochemotherapy typically
employs red light (~ 620 nm) which is suitable for activation of established photodynamic agents.27
We are therefore investigating methods to achieve photoactivation of PtIV-azido complexes at a
variety of wavelengths. Here we describe the synthesis and characterisation of new PtIV azido
complexes 46 and their synthetic PtII precursors 13 (Figure 1); although complexes 1 and 2 have
been previously reported18,28 we present here further characterisation, including x-ray
crystallographic structures.
Results
Dichlorido PtII compounds [Pt(bpy)Cl2], [Pt(phen)Cl2] and trans-[PtCl2(py)2] were prepared by
literature methods.29,30 The chloride ligands were then substituted by azido ligands by stirring the
complexes with an excess of sodium azide in DMF. The reaction of complexes 1–3 with H2O2 in
acetic acid resulted in oxidation.31,32 The main products in all three cases were the monohydroxido,
monoacetato species [Pt(L)(N3)2(OAc)(OH)] (L = bpy, phen, (py)2), which were then readily
converted to the diacetato complexes 46 by stirring in acetic anhydride.
Crystal Structures
Square-planar PtII bipyridine and phenanthroline complexes (1 and 2) both crystallised in a
monoclinic crystal system. In both systems deviation from square-planar geometry is observed; the
angle(s) which the platinum azide group Pt-Nα makes with the plane defined by N(ring)-Pt-N(ring) is
1.54 o for 1 (which contains a two-fold axis of symmetry) and 3.02 o and 2.24 o for 2. For 1, angles
at the coordinated azide group (Pt–Nα–Nβ) are 119.3(2)° with Pt–Nα and Pt–N(ring) bond lengths of
2.034(3) Å and 2.008(3) Å, respectively. For 2, angles at the coordinated azide group are 121.8(4)°
and 125.1(4)° with Pt–Nα bond lengths of 2.022(6) Å and 2.037(5) Å and Pt–N(ring) lengths of
2.011(6) Å and 2.011(5) Å, respectively. Complex 3 also crystallised in a monoclinic crystal system
containing a two-fold axis of symmetry. The geometry around the platinum centre is significantly
distorted from square-planar geometry and the pyridine rings demonstrate positional disorder. The
pyridine ring is disordered approximately equally over two
orientations. The two components were restrained to have similar bond
distances and angles. For 3, angles at the coordinated azide group (Pt–Nα–Nβ) are 125.4(5)° with
4Nα–Pt–Nα angles and Pt–Nα bond lengths of 146.7(4)° and 2.036(7) Å respectively. For the
structures and crystallographic parameters of 1, 2 and 3 see Figure S1 and Table 1 respectively.
Each of the PtIV complexes (4–6) crystallised in a different crystal system and space group,
however they all contain a two-fold axis of symmetry (Figure 2) and adopt approximate octahedral
geometry; the O–Pt–O angles are 179.18(14)° (4), 165.12(19)° (5) and 179.994° (6). The Pt–Nα
distances are 2.022(3) Å, 2.032(4) Å and 2.049(6) Å respectively, and the Pt–N(ring) distances
2.033(3) Å, 2.052(4) Å and 2.028(6) Å, respectively. The angles at the coordinated azide groups are
115.0(3)°, 118.5(4)° and 114.9(5)°, respectively. The crystallographic parameters are given in Table
1 and a selection of key bond lengths and angles are shown in Table 2.
In general, the structures optimized by DFT calculations are in good agreement with those obtained
from X-ray crystallography. DFT tended to overestimate bond lengths of 1–6, particularly in the
case of Pt (bpy, phen, py) where distances are up to 0.06 Å longer. In the case of complexes 1
and 2, the PtN1 and PtN2 bond lengths are underestimated. Optimising the geometry in the gas
phase rather than the condensed phase is a possible source of this inconsistency33 although recent
results suggest that this is unlikely to significantly affect the values34. DFT-calculated angles are
within a few degrees of the X-ray values; the only exception being the angles relating to the azide
ligands; for all complexes, X-ray and DFT gave differences in the orientation of the N3 groups
although this is unlikely to be energetically significant. Data are summarized in the Supplementary
Information (Tables S14).
Orbital Analysis
The PtIV complexes 4 (bpy) and 5 (phen) have similar frontier orbitals, those of 4 are shown in
Figure 3. The HOMOs of 4 and 5 are mainly azide-based, with a small contribution from Pt. The
HOMO shows a bonding interaction between the two azide N atoms, while it is antibonding with
respect to the NN and PtNα bonds. The HOMO1 is similar in shape to the HOMO, while the
HOMO2 is more diffuse, having contributions also from the acetate groups and the chelating
ligand. The LUMO and LUMO+1 of 4 and 5 are strongly antibonding orbitals; the LUMO is
antibonding towards the PtN(azide) and PtN(bpy, phen) bonds, LUMO+1 is antibonding towards
PtN(azide) and PtO(Ac) bonds. Higher in energy, the LUMO+2, LUMO+3 and LUMO+4 are all
bpy- or phen-based. In complex 6 the HOMO is azide-centred. In the HOMO1 and HOMO2 the
acetate character progressively increases, and the HOMO3 is mainly acetate-based. In 6, the
5LUMO has antibonding character for the PtN(azide) bonds, while the LUMO+1 is antibonding
towards both acetate and azide ligands. Both the LUMO+2 and LUMO+3 are py-centred.
The PtII complexes show similar features in the frontier orbitals which play a significant role
in the UV-vis spectra. However, there is a major and fundamental difference in the unoccupied
orbitals. The LUMO and LUMO+1 of 1 and 2 are bpy- or phen-based * orbitals, those of 1 are
shown in Figure 3. The lowest-energy antibonding orbital is LUMO+2 which lies ca.1 eV above
LUMO+1. Complex 3 has orbitals that resemble those of 6, differing in that the LUMO has lost its
antibonding character and the other empty orbitals are of higher energy.
UV-vis spectroscopy and TD-DFT singlet transitions
Computed UV-vis spectra of complexes 1 and 2 were in agreement with previously published
data.18 Theoretical UV-vis spectra of 46 were calculated by TD-DFT with the CPCM solvent
model and then overlaid with the experimental spectra which were recorded in water (Figure 4).
The most representative electron density difference maps for the singlet transitions of 46 are also
reported in Figure 4. Experimental and theoretical data are summarized in Tables 35.
Complex 4 shows a maximum at 250 nm and a pronounced shoulder around 310 nm; a weak
absorbance is also present at ca. 350 nm. Similarly, the main absorbance of 5 is at 272 nm and a
shoulder, although significantly less pronounced, is visible at 300 nm. In addition, 5 has two weak
bands in the range 330360 nm. TD-DFT calculations performed without relativistic correction
give satisfactory results in the case of 5, despite a small red shift in the absorbance energies. On the
contrary, less satisfactory is the determination of the 310-nm band intensity for 4. However, the
general character of the electronic transitions of 4 was confirmed by performing calculations with
different software (see Computational Details and Supplementary Information). For both
complexes, the lowest-energy absorbance is due to ligand-to-metal charge transfer (LMCT)23 states
(state S6 for both 4 and 5), where electron density migrates from the acetate groups to the metal. At
higher energy, the transitions composing the shoulder are a mixture of LMCT (N3  Pt) and
ligand-to-ligand charge-transfer states (LLCT, N3  bpy, phen). LMCTs are predominant in 4,
while LLCTs are predominant in 5. The highest-energy bands are of mixed character in both
complexes, and bpy and phen have marginal roles.
For complex 6, the band centred at 304 nm has an almost pure LMCT (py  Pt,N3) character.35
TDDFT assigns the band at 260 nm to LLCT transitions (OAc  py), but underestimates their
6oscillator strength values. The λmax of complex 6 is shifted towards the red region compared to
complexes 4 and 5 which is due to the trans geometry of the azide ligands.36
Photochemistry of 4–6
Aqueous solutions of platinum (IV) complexes 4–6 (ca. 50 μM) were irradiated with UVA light
(power ca. 1.5 mW/cm2), and UV-visible spectra were recorded after 0, 1, 5, 15, 30 and 60 min of
irradiation (see Figure 5). Marked changes in the spectra occurred following irradiation. For 4 and
5, a large and weak band appeared at ca. 370 nm corresponding to formation of PtII species,18 and a
decrease in the UV band at ca. 250 nm was observed. Complex 6 behaved slightly differently since
no absorption appeared at wavelengths longer than 350 nm upon irradiation, with a new band
appearing at 250 nm while at 300 nm there was a significant decrease in absorbance. The pH of the
non-buffered aqueous solutions of 4, 5 and 6 after 2h UVA irradiation did not increase. Following
irradiation of 6, ESI-MS analysis (positive ion mode) showed peaks corresponding to [Pt(OH)2(py)2
+ H]+ (obs: 388.4 m/z, calc: 388.1 m/z) and its fragment [Pt(OH)(py)2]+ (obs: 370.4 m/z, calc: 371.1
m/z) (see Figure S2).
Photoactivation studies of complexes 4–6 using visible (green) light (514 nm, 60 mW/cm2)
were carried out on 1 mM 90% D2O / 10% d6-acetone solutions, acetone being used to aid
dissolution. 1H NMR spectra were recorded after 0, 15, 30 and 60 min irradiation. Changes in the
spectra for 4–6 were observed following irradiation with the acetate region providing the clearest
picture of speciation; as judged by the free and bound acetate resonances (Figure 6). Complex 6
gave rise to free acetate the fastest, with ca. 85% reacting after only 15 min of irradiation, and after
30 min only a very small peak corresponding to bound acetate was visible. In contrast, only half of
complexes 4 and 5 had reacted after 30 min, and after 60 min ca. 40% of each of the original
compounds remained.
Discussion
The standard protocol of using an aqueous solution of silver nitrate to remove chlorides from a PtII
centre to produce reactive aqua adducts reportedly produces oxygen-bridged dimers when ligands
such as bipyridine or phenanthroline are present.37 For this reason we employed the method of
direct substitution of chloride by azide in DMF. Problems were encountered while attempting to
oxidise the PtII complexes 1–3 by the method previously used to generate PtIV azides (H2O2 added
to an aqueous suspension of the PtII diazide species)21,36,38 since complexes 1–3 required harsher
7conditions to undergo oxidation. The use of acetic acid followed by acetic anhydride allowed us to
oxidise these complexes and to synthesise the diacetato PtIV products 4–6 in good yield.
Although there are many examples of PtIV bipyridine and phenanthroline compounds with
halide or alkyl ligands39 complexes 4–6 appear to be the first reported PtIV pyridine, phenanthroline
and bis-pyridine azido complexes. The oxidation of the PtII-azido precursors is hindered by their
sensitivity to both heat and light. In contrast, compounds such as [Pt(L)R2] (L = bpy, phen; R =
alkyl, aryl) are easily oxidised by H2O2,39g,h indeed such reactions are reported to proceed rapidly at
room temperature. Ligands such as methyl form strong σ-bonds to PtII, raising the energy of the
HOMO and thereby making the PtII species more susceptible to oxidation.39h Oxidation of halogen-
containing complexes [Pt(L)X2] (X = Cl, Br, I) with H2O2 is much more difficult due to the greater
ionic component in Pt–X bonds and the resultant reduced donation of charge to the metal centre.
Halido PtIV -diimine complexes have been produced by using oxidants such as Cl2, Br2 and/or
more forcing conditions (e.g. high temperature or photocatalysis).39d-f,i None of these synthetic
routes are suitable for oxidising [PtII(L)(N3)2] (L = bpy, phen) diazido complexes to a PtIV complex
with oxygen bound in axial positions. The preference for groups such as OH or OCOCH3 in the
axial positions arises from their stabilising effect on PtIV, which is a desirable feature for potential
photoactivatable prodrugs since compounds containing axial chloride ligands are often readily
reduced in vivo without irradiation.10
The oxidation route we employed to synthesize the diacetato complexes, which proceeds via
initial formation of the monohydroxido monoacetato species [Pt(L)(N3)2(OAc)(OH)] (L = bpy,
phen, (py)2) in H2O/acetic acid, is anticipated to occur with retention of the OH oxygen in the
second step, in accordance with the literature.40 The oxidation step may proceed directly to the
mixed OH/OAc complex with participation from the acetate anion41 or via a dihydroxido species,
followed by nucleophilic substitution of the acetate. If the oxidation occurs via the latter
mechanism, the first step in the substitution is anticipated to be protonation of OH. Since only the
monosubsituted species [Pt(L)(N3)2(OAc)(OH)] is isolated, this would imply that the pKaH of the
second axial hydroxido is lower than the pKa of acetic acid (4.75).42
Crystal structures and DFT electrostatic potentials
The bond lengths and angles of complexes 1 and 2 (Tables S1 and S2) are comparable to similar
reported structures.43,44 For a discussion of the crystal packing of 1 see the supporting information.
Complex 3 shows a significant distortion from square-planar geometry which can be
attributed to steric interactions between the azide ligands and the pyridine rings. Deviations from
8square planar towards tetrahedral geometry are common for PtII complexes containing bulky or
rigid ligands.45,46 Complex 3 is symmetrical with regard to the azido ligands, the bond lengths
within the azido groups are consistent with those found in other azido compounds.47,48
The azide bond lengths and angles for complexes 4–6 (Table 2) compare well with other
platinum azide structures.36 The Pt–N(ring) bond lengths of 4–6 are ca. 0.02–0.04 Å longer than those
of the corresponding PtII compounds (1–3); a difference which has also been reported for
[PtIV(bpy)Cl4]9d and [PtII(bpy)Cl2].44
Distortion from ideal octahedral geometry occurs in all three PtIV structures (4–6). The axial
PtO(acetate) bonds are bent with respect to the plane formed by the equatorial ligands in 4 and 5,
possibly to minimise intramolecular repulsions; the bending of the axial acetate bond in similar PtIV
complexes has been attributed to intramolecular hydrogen bonding.49,50 The restricted bites of the
chelating bipyridine and phenanthroline ligands (ca. 80º) in 4 and 5 also cause distortion.
Complexes 4–6 contain intermolecular hydrogen-bonded networks, and some weak π-π stacking
exists between molecules of complex 5. Interestingly, complex 4 shows a weak AcO···HC(bpy)
interaction which is not present in 5, where acetate groups are interacting with the  electrons of the
phen ligand. Figure 7 shows the changes in the electrostatic potential surfaces of 2 and 5 due to
such an interaction.
Photochemistry and TD-DFT
The photoreactions of PtIV azide complexes are of interest due to the potential use of such
complexes as photoactivated anticancer agents.36
Absence of isosbestic points indicates that more than one photoproduct is obtained by
irradiation. According to calculations and experimental work done on similar systems,51 it is
reasonable to assume that both azide and acetate ligands can easily be displaced by solvent
molecules upon irradiation. In fact, the strongly antibonding character of LUMO and LUMO+1
suggests that all the transitions having contributions from such orbitals are dissociative. As shown
in Figure 6, formation of free acetate in irradiated samples can be easily monitored by 1H NMR.
Furthermore, ligand dissociation can be confidently associated with reduction of PtIV to PtII,
consistent with the appearance of the MLCT-like absorption at 370 nm (for 4 and 5) and the
reported behaviour of [PtIV(bpy)Cl4].39c
The UV-vis spectra of complexes 4 and 5 after 2 h UVA irradiation were remarkably similar
to those reported52 for [Pt(L)(OH)2] and [{Pt(L)(μ-OH)}2] (L = bpy, phen) suggesting that these
were significant photoproducts. ESI-MS of irradiated solutions of 6 revealed that the py ligands can
9be retained as the acetate is lost, with species such as [Pt(OH)2(py)2 + H]+ detected (Figure S2);
such aqua adducts would be effective for DNA binding if photoactivation is carried out in vivo. No
dimers were observed, perhaps hindered by the trans geometry.
The lack of increase in pH of the solutions of 4–6 after 2 h UVA irradiation is in contrast to
solutions of analogous PtIV-azido compounds containing NH3 ligands for which a sharp increase in
pH to >10 was seen under similar conditions.51 We suggest that this is because continued irradiation
of the NH3-containing complexes results in release of the coordinated ammine; it is not clear
whether bpy, phen and py are released on continued irradiation, but they are significantly less basic
than NH3.
Complexes 4–6 underwent photoreaction with green light (514 nm) giving rise to free
acetate. Although the 1H NMR spectra of 4 clearly show an NMR peak for the released acetate,
irradiation of 5 and 6 produced more complicated spectra, possibly due to formation of significant
mono-acetato Pt intermediates or through weak electrostatic interactions of the free acetate with the
photoproducts. Although the absorbance in the UV-vis spectrum at 514 nm for all three complexes
is very low, the photodissociative behaviour may be explained by the computed singlet transitions
in Table 6. Low-energy transitions of a highly dissociative nature exist for complexes 46 (all
involving LUMO and LUMO+1) despite the very small oscillator strengths; excitation of these
transitions with green light can evidently still produce ligand dissociation.
Experimental
Methods and Materials
Materials. Silver nitrate, pyridine (py), d6-acetone, d6-DMSO, D2O and 1,4-dioxane were
purchased from Aldrich, NaN3, HCl (37%), acetic anhydride and acetic acid (> 99%) from Fisher,
H2O2 and 1,10-phenanthroline (phen) from Sigma, K2[PtCl4] from Alfa Aesar, and 2,2'-bipyridine
(bpy) from Acros.
NMR Spectroscopy. NMR spectra were recorded at 298 K on a Bruker DMX500 (1H: 500.13
MHz) magnet. Samples were prepared in d6-acetone, d6-DMSO, D2O or 90% H2O / 10% D2O with
1H chemical shifts referenced internally to dioxane ( 3.75 ppm in D2O;  3.764 ppm for 90% H2O
/ 10% D2O). All data were processed with XWIN-NMR software (Version 3.6, Bruker, UK Ltd.).
All J values are quoted in Hz.
Mass Spectrometry. Positive ion electrospray mass spectrometry (ESI-MS) was performed on a
Platform II Mass Spectrometer (Micromass, Manchester, UK). The capillary voltage was 3.5 V and
the cone voltage typically varied between 5 and 30 V. The source temperature was adjusted
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depending on the solvent. Data were acquired and processed with Mass Lynx (Version 2.0)
software.
UV-visible Spectroscopy. UV-visible electronic absorption spectra were recorded on a Varian Cary
300 UV-visible spectrophotometer in 1-cm path-length cuvettes. Data were processed with Microcal
Origin 5.0.
Light Sources. The ultraviolet light source used for photochemical studies was a broadband UVA
lamp (2 x 15 W tubes, model VL-215L; Merck Eurolab, Poole, UK) which operated with a
maximum output at 365 nm. Samples were irradiated at a distance of 10 cm from the lamp, where
the power was ca. 1.5 mW/cm2, delivering a dose of 10 J/cm2 over 2 h. The laser (Coherent Innova
70C Spectrum) used for irradiation at 514 nm was equipped with a fibre optic (FT-600-UMT,  =
600 m; Elliot Scientific) to enable delivery of light to a sample in the NMR probe. The fibre optic
was placed 2 mm above the solution in the NMR tube at which distance the power (ca. 60 mW/cm2)
was measured with a Coherent Fieldmate power meter (OP2-VIS head).
pH Measurements. pH values were measured with an Orion 710A pH meter equipped with a
chloride-free micro-combination electrode (Aldrich) calibrated with Aldrich standard buffers (pH 4,
7 and 10).
X-ray Crystallography. Diffraction data were collected with Mo-K radiation (λ = 0.71073 Å) on
a Bruker Smart Apex CCD diffractometer equipped with an Oxford Cryosystems low-temperature
device operating at 150 K. Data were corrected for absorption using the program SADABS.53 The
crystal structures of 1, 4 and 5 were solved by Patterson methods (SHELXS54 or DIRDIF55) The
structures of 2, 3 and 6 were solved by direct methods (DIRDIF55 or SIR9256). All structures were
refined against F2 using SHELXL54 or CRYSTALS.57 The crystal structures of 1 – 6 have been
deposited in the Cambridge Crystallographic Data Centre under the accession numbers CCDC
709183,709182, 709184, 709185, 709186 and 709187 respectively, and the cif files are available in
the Supplementary Information. ORTEP diagrams were generated using ORTEP 3v258 and POV-
Ray 3.6.59
Computational details. The calculations were generally performed with the Gaussian 03 (G03)
program60 employing the DFT method, Becke three-parameter hybrid exchange functional61 and
Lee-Yang-Parr’s gradient corrected correlation functional62 (B3LYP). The LanL2DZ basis set63 and
effective core potential were used for the Pt atom and the 6-31G** basis set64 was used for all other
atoms. Geometry optimizations of 16 in the ground state were performed in the gas phase from the
x-ray crystallographic structure and the nature of all stationary points was confirmed by normal
mode analysis. The conductor-like polarizable continuum model method (CPCM)65 with water as
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solvent was used to calculate the electronic structure and the excited states of 16 in solution.
Thirty-two singlet excited states and the corresponding oscillator strengths were determined with a
Time-dependent Density Functional Theory (TD-DFT)66 calculation. The computational results are
summarized in Tables 35 and in the Supplementary Information, where only electronic transitions
with an oscillator strength value (f) higher than 0.01 are reported. The electronic distribution and the
localization of the singlet excited states were visualized using the electron density difference maps
(EDDMs).67 GaussSum 1.0568 was used for EDDMs calculations and for the electronic spectrum
simulation.
Additional geometry optimizations and energy calculations on 4 were performed using the
Amsterdam Density Functional 2007 program (ADF) at the gradient-corrected density functional
theory (DFT) level using BP86 functional in combination with the TZP basis sets.69 A small frozen
core was used for efficient treatment of the inner atomic shells. Uncontracted Slater-type orbitals
(STOs) were used as basis functions. Relativistic effects were considered by the zeroth-order
regular approximation (ZORA). Electronic excitation energies were computed with the
asymptotically correct XC potential obtained with the statistical average of (model) orbital
potentials (SAOP)70 using scalar relativistic Time-Dependent Density Functional Theory (TD-
DFT) in the ADF program.
Syntheses. Caution! No problems were encountered during this work, however heavy metal azides
are known to be shock sensitive detonators, therefore it is essential that any platinum azide
compound is handled with care.
[Pt(bpy)(N3)2] (1). [Pt(bpy)Cl2] (98.5 mg) was prepared from K2[PtCl4] and 2,2'-bipyridine in an
89% yield by the literature method.29 The isolated product was suspended in DMF (15 mL) and
NaN3 (0.152 g, 2.14 mmol) added. After stirring at 298 K in the dark for 3 d, the volume was
reduced to 12 mL and H2O added to precipitate the product. [Pt(bpy)(N3)2] was collected by
filtration, washed with water, ethanol and diethyl ether, then dried under vacuum (93.1 mg, 91.7 %).
δH (500 MHz; d6-DMSO; dioxane) 8.91 (d, H6,6, 1J5,6 5.7, 2H), 8.57 (d, H3,3, 1J3,4 8.0, 2H), 8.40 (t,
H4,4, 1J4,5 7.7, 2H), 7.82 (t, H5,5, 2H). Crystals suitable for X-ray structure determination were
grown from DMF at 277 K.
[Pt(phen)(N3)2] (2). The synthesis of [Pt(phen)Cl2] and [Pt(phen)(N3)2] was carried out by a similar
method as described for the corresponding 2,2'-bipyridine complexes. From [Pt(phen)Cl2] (100 mg)
obtained 2 (85.2 mg, 82.8 %). δH (500 MHz; d6-DMSO, dioxane): 9.20 (d, H2,9, 1J 5.3, 2H), 9.02 (d,
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H4,7, 1J 8.3, 2H), 8.28 (s, H5,6, 2H), 8.14 (d, H3,8, 2H). Crystals suitable for X-ray structure
determination were grown from DMF at 277 K.
Trans-[Pt(N3)2(py)2] (3). Trans-[PtCl2(py)2] (166.5 mg) was synthesised by the literature method30
and converted to the diazido complex 3 (162.6 mg, 94.7 %) by the same method used for
preparation of 1 and 2. δH (500 MHz; d6-acetone, dioxane): 8.86 (dd, Ho, 1Jo,m 6.6, 2Jo,p 1.7, 4H),
8.12 (tt, Hp, 1Jp,m 7.7, 2H), 7.67 (dd, Hm, 4H). λmax (DMF)/nm: 273 (/M 1 cm1 14 500) and 328sh
(3456). Crystals suitable for X-ray structure determination were grown from pyridine at 277 K.
Trans, cis-[Pt(bpy)(OAc)2(N3)2] (4). [Pt(bpy)(N3)2] (10.0 mg, 0.023 mmol) was suspended in
acetic acid (> 99 %, 4 mL) and H2O2 (30 %, 0.23 mmol, 17 L) added. After stirring at 298 K for 2
h, all the solvent was removed from the bright orange solution and acetic anhydride (3 mL) added.
After stirring at 298 K for 3 d the solution was again reduced to dryness and ice-cold H2O added.
The yellow solid was collected by filtration, washed with water, ethanol and ether and dried under
vacuum. Crystallisation from a 50:50 acetone/water solution at 277 K gave 4 (7.3 mg, 57.4 %). λmax
(H2O)/nm: 250 (/M 1 cm1 19100), 304 (11400) and 315 (9760). δH (500 MHz; d6-acetone,
dioxane): 9.30 (d, H6,6, 1J5,6 5.9, 2H), 8.69 (d, H3,3, 1J3,4 7.9, 2H), 8.47 (t, H4,4, 1J4,5 7.9, 2H), 8.04
(t, H5,5, 2H), 1.65 (s, CH3, 6H). ESI-MS m/z: 554.1 [M + H]+; 576.0 [M + Na]+. Crystals suitable
for X-ray structure determination were grown from water at 277 K.
Trans, cis-[Pt(phen)(OAc)2(N3)2] (5). Synthesised from 2 by the oxidation method outlined for
synthesis of 4. Crystals suitable for structure determination were grown from H2O at 277 K. Yield
of 5: 4.7 mg, 42.4 %. UV-vis (H2O)/nm: 272 (/M 1 cm1 17900), 300sh (5840), 337 (1060) and
352 (796). δH (500 MHz; d6-acetone, dioxane): 9.56 (d, H2,9, 1J 5.5, 2H), 9.06 (d, H4,7, 1J 8.1, 2H),
8.39 (s, H5,6, 2H), 8.36 (d, H3,8, 2H), 1.56 (s, CH3, 3H). ESI-MS m/z: 578.3 [M + H]+, 600.3 [M +
Na]+, 616.4 [M + K]+.
Trans, trans, trans-[Pt(OAc)2(N3)2(py)2] (6). Synthesised from 3 by the oxidation method outlined
for synthesis of 4. Yield of 6: 6.7 mg, 56.9 %. Crystals suitable for structure determination were
grown from H2O at 277 K. UV-vis (H2O)/nm: 259 (/M1 cm1 12500) and 307 (16900). δH (500
MHz; d6-acetone, dioxane): 8.95 (d, Ho, 1J 5.9, 4H), 8.30 (t, Hp, 1J 7.5, 2H), 7.83 (t, Hm, 4H), 1.92
(s, CH3, 6H). ESI-MS m/z: 556.4 [M + H]+, 578.3 [M + Na]+, 594.5 [M + K]+.
Conclusions
Complexes 46 are the first reported examples of PtIV-azido complexes which contain
phenanthroline, bipyridine and bispyridine ligands. The x-ray crystal structures of these complexes
show near-octahedral geometry for 4 and 6, with a significant distortion of the axial groups to give a
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OPtO angle of 165.12° for complex 5. Irradiation of complexes 46 with both UVA (365 nm)
and green (514 nm) light results in reduction of the complexes to PtII species, with release of one or
both of the axial acetate ligands. Generation of reactive aqua species (through azide release)
provides promising novel mechanisms for cytotoxic activity against cancer cells. Irradiation of
complexes 4–6 in water is not accompanied by a large increase in pH as was detected for the
previously-reported ammine complex cis, trans, cis-[Pt(N3)2(OH)2(NH3)2],51 probably due to the
reduced lability of the α-diimine ligands on photoactivation, compared to NH3, in agreement with
the mass spectrometric data. TDDFT calculations enabled us to show the presence of strongly
dissociative low energy transitions for complexes 4–6 since we could identify key orbitals and
excited states, their relative positions and dependence on the nature of the ligands. In future work
we hope to predict the electronic properties of complexes prior to synthesis. This will allow us to
focus our efforts on compounds which exhibit the most appropriate absorption bands.
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Tables
Table 1. Crystallographic data for [Pt(bpy)(N3)2] (1), [Pt(phen)(N3)2] (2), trans-[Pt(N3)2(py)2] (3),
trans, cis-[Pt(bpy)(OAc)2(N3)2] (4), trans, cis-[Pt(phen)(OAc)2(N3)2] (5) and trans, trans, trans-
[Pt(OAc)2(N3)2(py)2] (6).
Complex
Parameter
1 2 3 4 5 6
Empirical formula C10H8N8Pt C12H8N8Pt C10H10N8Pt C14H14N8O4Pt C16H14N8O4Pt C14H16N8O4Pt
Formula weight 435.32 459.34 437.33 553.42 577.43 555.42
Crystal system Monoclinic Monoclinic Monoclinic Orthorhombic Monoclinic Triclinic
Space group C2/c C2/c I121 Pbcn P2/n P-1
a (Å) 10.9346(5) 19.3584(7) 11.6121(5) 8.0488(4) 7.0303(1) 6.9480(3)
b (Å) 15.3328(8) 10.1802(4) 3.8371(2) 14.1103(7) 11.7849(2) 8.2197(4)
c (Å) 7.0453(4) 13.8692(4) 14.1714(9) 15.3280(7) 11.3271(2) 8.6473(4)
 () 90 90 90 90 90 92.136(3)
 () 94.717(3) 113.816(2) 102.756(2) 90 101.236(1) 111.574(3)
 () 90 90 90 90 90 101.038(3)
Z 4 8 2 4 2 1
ρcalcd (mg/m3) 2.456 2.440 2.358 2.112 2.083 2.060
μcalcd (mm-1) 11.919 11.230 11.392 8.101 7.665 7.877
Volume (Å3) 1177.20(11) 2500.49(16) 615.85(6) 1740.82(15) 920.48(3) 447.61(4)
Conventional R 0.0192 0.0326 0.0264 0.0243 0.0305 0.0350
wR2 0.0478 0.0825 0.0690 0.0582 0.0690 0.0913
Independent
reflections
1453 3057 1429 2307 2454 2121
No. reflections
measured
6926 9019 2838 21880 14648 5315
Rint 0.03 0.036 0.045 0.0377 0.027 0.041
Data/Restraints/Pa
rameters
1452/0/87 3057/0/190 1423/13/71 2307/0/124 2453/20/142 2121/0/125
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Table 2. Selected bond lengths (Å) and angles (º) for complexes 4–6. The azide ligands are labelled
PtNNβNγ and the pyridyl nitrogens as NRing.
Complex
Bond / Angle
4 5 6
PtN(Ring) 2.033(3) 2.052(4) 2.028(6)
PtO 2.020(2) 2.001(3) 2.007(5)
PtN(α1) 2.022(3) 2.032(4) 2.049(6)
N(α1)N(β1) 1.225(5) 1.175(6) 1.224(9)
N(β1)N(γ1) 1.147(5) 1.154(6) 1.142(10)
PtN(α1)N(β1) 115.0(3) 118.5(4) 114.9(5)
N(α1)N(β1)N(γ1) 175.2(5) 173.1(5) 176.0(8)
N(Ring)PtN(Ring) 80.07(17) 81.2(2) 179.994
OPtO 179.18(14) 165.12(19) 179.994
N(1)PtN(2) 89.5(2) 96.1(2) 179.994
N(Ring)PtN(1) 175.25(13) 172.40(16) 89.3(2)
N(Ring)PtN(2) 95.22(14) 91.40(16) 90.7(2)
N(Ring)PtO 93.82(11) 95.84(13) 95.6(2)
N(Ring2)PtO 85.55(11) 95.44(14) 84.4(2)
N(1)PtO 95.50(12) 83.17(16) 86.4(2)
N(2)PtO 85.08(12) 86.90(16) 93.6(2)
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Table 3. Experimental and calculated absorption properties of 4.
max, nm
 (M1 cm1) Tr
a Composition Energy,eV (nm)
Oscillator
Strength
Assignment
350 6 HOMO2LUMO+1 (62%)HOMO1 LUMO+1 (17%) 3.43 (361) 0.0105 LMCT
16 HOMO7LUMO (17%)HOMO6L+1 (67%) 3.98 (312) 0.0127 LMCT
18 HOMO7LUMO+1 (47%)HOMO6LUMO (40%) 4.04 (307) 0.0161 LMCT
304 (11402)
and
315 (9756)
19
HOMO7LUMO (11%)
HOMO4LUMO+2 (54%)
HOMO3LUMO+2 (17%)
4.07 (304) 0.0525 LLCT
20
HOMO9LUMO (15%)
HOMO8LUMO (28%)
HOMO7LUMO+1 (30%)
HOMO6LUMO (16%)
4.31(287) 0.0969 LMCT
21
HOMO7LUMO (37%)
HOMO6LUMO+1 (10%)
HOMO5LUMO+2 (35%)
4.32 (287) 0.0496 LMCT/LLCT
22
HOMO9LUMO+1 (21%)
HOMO8LUMO+1 (25%)
HOMO5LUMO+2 (22%)
4.42 (280) 0.1933 LLCT/MLCT
23
HOMO9LUMO+1 (22%)
HOMO8LUMO+1 (27%)
HOMO5LUMO+2 (20%)
4.44 (279) 0.1581 LLCT/MLCT
25 HOMO9LUMO (19%)HOMO8LUMO (65%) 4.48 (277) 0.0556 LLCT/MLCT
26 HOMOLUMO+3 (91%) 4.56 (272) 0.0314 LLCT
28 HOMO9LUMO (57%) 4.61 (268) 0.1447 LMCT
29 HOMOLUMO+4 (83%) 4.65 (267) 0.047 LLCT
250
(19102)
30 HOMO2LUMO+3 (80%)HOMO1LUMO+3 (14%) 4.76 (260) 0.0119 LLCT
a Tr = transition number as obtained in the TDDFT calculation output.
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Table 4. Experimental and calculated absorption properties of 5.
max, nm
 (M1 cm1) Tr
a Composition Energy,eV (nm)
Oscillator
Strength
Assignment
337 (1060)
and
352 (796)
6
HOMO3LUMO +1 (10%)
HOMO2LUMO +1 (35%)
HOMO1LUMO +1 (43%)
3.38 (367) 0.0103 LMCT
16
HOMO2LUMO +2 (55%)
HOMO1LUMO +2 (15%)
HOMOLUMO +3 (20%)
3.89 (318) 0.0249 LLCT
17 HOMO2LUMO +3 (18%)HOMO1LUMO +3 (76%) 3.90 (317) 0.0125 LLCT
300
(5840)
19 HOMO3LUMO +2 (70%)HOMO2LUMO +2 (11%) 3.96 (313) 0.0288 LLCT/IL
27 HOMO6LUMO +2 (20%)HOMO3LUMO +3 (52%) 4.27 (290) 0.0131 LLCT
28
HOMO10LUMO (23%)
HOMO9LUMO (24%)
HOMO8LUMO +1 (26%)
HOMO7LUMO (14%)
4.28 (290) 0.1048 LMCT
29
HOMO8LUMO (29%)
HOMO7LUMO +1 (16%)
HOMO6LUMO +2 (19%)
4.33 (287) 0.1087 LMCT/d-d
30 HOMO9LUMO (51%)HOMO5LUMO +3 (34%) 4.40 (282) 0.1474
Mixed
31 HOMO10L+1 (34%)HOMO9LUMO +1 (50%) 4.42 (281) 0.0225 LMCT
272
(17900)
32
HOMO10LUMO (24%)
HOMO9LUMO (22%)
HOMO5LUMO +3 (39%)
4.45 (279) 0.0242 Mixed
a Tr = transition number as obtained in the TDDFT calculation output.
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Table 5. Experimental and calculated absorption properties of 6.
max, nm
 (M1 cm1) Tr
a Composition Energy,eV (nm)
Oscillator
Strength
Assignment
9
HOMO4LUMO (11%)
HOMO4 LUMO+1 (65%)
HOMO2LUMO+1 (20%)
3.75 (330) 0.0424 LMCT
10 HOMO4LUMO+1 (18%)HOMO2LUMO+1 (76%) 3.79 (327) 0.0116 LMCT
12 HOMO6LUMO (64%)HOMO4LUMO (16%) 4.01 (309) 0.1278 LMCT
307
(16900)
13
HOMO6LUMO (28%)
HOMO4LUMO (40%)
HOMO4LUMO+1 (10%)
4.06 (305) 0.3458 LMCT
19 HOMO10LUMO (72%)HOMO6LUMO+1 (16%) 4.46 (277) 0.0208 LMCT
21 HOMO10LUMO (12%)HOMO6LUMO+1 (72%) 4.51 (275) 0.011 LMCT
25 HOMO3 LUMO+2 (75%)HOMO2LUMO+3 (10%) 4.67 (265) 0.0357 LLCT
259
(12500)
29 HOMO1LUMO+3 (87%) 4.82 (257) 0.0155 LLCT
a Tr = transition number as obtained in the TDDFT calculation output.
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Table 6. Calculated low-energy absorption properties of 46.
Tra Composition Energy,eV (nm)
Oscillator
Strength
4
1 HOMOLUMO (91%) 2.60 (477) 0.0007
2 HOMO1LUMO (25%),HOMOLUMO+1 (66%) 2.80 (442) 0.0001
3 HOMO1LUMO (62%)HOMOLUMO +1 (28%) 3.10 (400) 0.0027
4 HOMO2LUMO+1 (17%),
HOMO1LUMO+1 (76%)
3.25 (381) 0.0019
5
1 HOMOLUMO (91%) 2.55 (485) 0.0006
2
HOMO2LUMO (17%),
HOMO1LUMO (-12%),
HOMOLUMO+1 (64%)
2.77 (447) 0.0001
3
HOMO2LUMO (-29%),
HOMO1LUMO (36%),
HOMOLUMO+1 (30%)
3.06 (405) 0.0032
4 HOMO2LUMO+1 (49%),HOMO1LUMO+1 (-44%) 3.22 (384) 0.0032
6
1 HOMOLUMO (93%) 2.38 (520) 0.0
2 HOMO2LUMO (-10%),HOMO1LUMO (85%) 2.91 (427) 0.0021
3 HOMOLUMO+1 (96%) 3.09 (401) 0.0
4 HOMO5LUMO (45%),
HOMO3LUMO (-41%)
3.27 (379) 0.0
5 HOMO2LUMO (82%),HOMO1LUMO (10%) 3.29 (377) 0.0068
a Tr = transition number as obtained in the TDDFT calculation output.
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Figure Captions
Figure 1. Structures of [Pt(bpy)(N3)2] (1), [Pt(phen)(N3)2] (2), trans-[Pt(N3)2(py)2] (3), trans, cis-
[Pt(OAc)2(N3)2(bpy)] (4), trans, cis-[Pt(OAc)2(N3)2(phen)] (5) and trans, trans, trans-
[Pt(OAc)2(N3)2(py)2] (6).
26
Figure 2. ORTEP plots of cis, trans-[Pt(bpy)(N3)2(OH)2] (4), cis, trans-[Pt(phen)(N3)2(OH)2] (5)
and (6) trans, trans, trans-[Pt(N3)2(OH)2(py)2] (6). Non-hydrogen atoms are represented by
Gaussian ellipsoids at the 50% probability level. Hydrogen atoms are shown with arbitrarily small
thermal parameters.
27
Figure 3. Selected orbitals for complexes [Pt(bpy)(N3)2] (1) and [Pt(OAc)2(N3)2(bpy)] (4).
28
Figure 4. Calculated (blue line) and experimental (black line) absorption spectra of 4–6 in H2O.
The excited states are shown as vertical bars with heights equal to the extinction coefficients.
EDDMs of selected singlet transitions, are reported on the right (electron density migrates from
light pink areas to purple ones). Theoretical curves and EDDMs were obtained using the program
GaussSum 1.05.68
29
Figure 5. UV-visible spectra of cis, trans-[Pt(bpy)(N3)2(OH)2] (4), cis, trans-[Pt(phen)(N3)2(OH)2]
(5) and trans, trans, trans-[Pt(N3)2(OH)2(py)2] (6) after UVA irradiation for 0 (─), 1 (─), 5 (─), 15
(─), 30 (─), 60 (─) and 120 (─) min. The arrows denote an increase or decrease of absorbance with
increasing irradiation time.
30
Figure 6. 1H NMR spectra showing loss of bound acetate on irradiation for complexes 4–6. The
appearance of free acetate was confirmed by spiking with acetic acid; the very slight change in
chemical shift of the free acetate is due to variation in the pH of the solutions.
Figure 7. Electrostatic potential (ESP) surface of complex 2 and 5. ESP surfaces are shown both in
space (with positive and negative regions shown in blue and red, respectively) and mapped on
electron densities (isovalue = 0.004) of the molecule (ESP colour scale is such that + →  in the
direction blue → green → yellow → orange → red).
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Figure S1. ORTEP plots of [Pt(bpy)(N3)2] (1) and [Pt(phen)(N3)2] (2). PLATON1 was
used to generate the plot for [Pt(py)2(N3)2] (3). Non-hydrogen atoms are represented
by Gaussian ellipsoids at the 50% probability level. Hydrogen atoms are shown with
arbitrarily small thermal parameters.
1 A. L. Spek, J. Appl. Cryst., 2003, 36, 7-13.
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Table S1. Selected X-ray bond distances (Å). For all complexes except 2; N1 = N2
= Nring; N(1) = N(, N(1) = N(2), N(1) = N(2). O1 and O2 are the axially-coordinated
oxygens.
ComplexBond 1 2 3 4 5 6
PtN1 2.009 2.011 1.992* 2.033(3) 2.051 2.028
PtN2 2.009 2.012 1.992* 2.033(3) 2.051 2.028
PtN(1) 2.034 2.037 2.036 2.022(3) 2.033 2.049
PtN( 2.034 2.022 2.036 2.022(3) 2.033 2.049
N(1)N(1) 1.191 1.182 1.188 1.225 1.174 1.224
N(1)N(1) 1.148 1.164 1.520 1.148 1.155 1.142
N(N( 1.191 1.179 1.188 1.225 1.174 1.224
N(2)N(2) 1.148 1.167 1.520 1.148 1.155 1.142
PtO1 - - - 2.020 2.001 2.007
PtO2 - - - 2.020 2.001 2.007
* disordered bond
Table S2. Selected X-ray angles (°)
ComplexAngle 1 2 3 4 5 6
N1PtN2 80.40(17) 81.6(2) 165.84* 80.07(17) 81.2(2) 179.994
N(PtN(2) 91.29(18) 95.0(2) 146.7(7) 89.5(2) 96.1(2) 179.994
Pt-N(N(N(† 176.81 179.65 -106.70 167.93 167.93 179.80
N1PtN(N(† -125.45 -164.38 -167.97* 142.39 155.71 123.42
N2PtN(N(† -125.45 -175.37 -167.97* 142.39 155.71 123.42
Pt-N(N(N(† 176.81 179.50 -106.70 167.93 167.93 179.80
O1PtO2 - - - 179.18(14) 165.12(19) 179.994
*Disordered bonds involved
† Torsion angle
4: NPtN(bpy) = 80.07°
(Ac)CO···HC contact 2.794 Å
5: NPtN(phen) = 81.19°
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Description of crystal packing in 1.
The two aromatic rings within a single molecule of the bpy complex 1 are skewed
with respect to each other, at an angle of 5.12º. The centroid-centroid distance (4.036
Å) and angle (5.12º) indicate that π-π stacking does not play a major role in the crystal
packing of 1. The structure of [Pt(phen)(N3)2] (2) consists of dimers which are π-π
stacked at a distance of 3.631 Å with a dihedral angle of 5.27. The Pt···Pt distance is
3.341 Å; it is not unusual to find such Pt···Pt interactions in square-planar PtII
complexes, with linear chains being commonly reported.1,2 The Pt…Pt distance is
however considerably longer than that which is found in complexes with well-defined
PtPt bonds.3
Table S3. Selected DFT bond distances (Å)
ComplexBond 1 2 3 4 5 6
PtN1 2.064 2.074 2.063 2.105 2.118 2.076
PtN2 2.064 2.074 2.063 2.105 2.118 2.076
PtN1 2.022 2.020 2.081 2.058 2.055 2.111
PtN 2.022 2.020 2.081 2.058 2.055 2.111
N1N1 1.223 1.223 1.223 1.230 1.230 1.226
N1N1 1.151 1.151 1.154 1.147 1.147 1.150
NN 1.223 1.223 1.223 1.230 1.230 1.226
N2N2 1.151 1.151 1.155 1.147 1.147 1.150
PtO1 - - - 2.058 2.059 2.061
PtO2 - - - 2.058 2.059 2.061
Table S4. Selected DFT angles (°)
ComplexAngle 1 2 3 4 5 6
N1PtN2 79.17 79.97 177.98 78.60 79.06 180
NPtN2 99.28 100.78 177.41 93.31 94.05 180
PtNNN 176.16 176.76 173.44 178.32 179.16 169.97
PtNNN 176.16 177.57 173.50 -178.32 -179.16 -169.97
N1PtNN -162.16 -166.64 -141.51 133.43 136.12 -77.09
N2PtNN -162.16 -166.64 -141.48 133.43 136.25 77.09
O1PtO2 - - - 168.08 167.19 180
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Figure S2. ESI-MS of compound 6 following UVA irradiation for 2 h showing
species in which the py ligand is still attached but from which the acetate group has
dissociated.
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Calculations with Gaussian
Figure S3: Theoretical UV-vis spectrum of 1
S7
Table S8: Complex 1, selected singlet transitions
No. Energy (eV)  (nm) Osc. Strength Major contribs
1 2.5767 481.18 0.0056 HOMO->LUMO (96%)
2 2.9652 418.13 0.1189 H-1->LUMO (92%)
3 3.019 410.69 0.0002 H-2->LUMO (14%),
HOMO->L+2 (73%)
HOMO->L+1 (-5%)
4 3.0662 404.36 0.0026 H-2->LUMO (83%),
HOMO->L+2 (-12%)
9 3.8372 323.11 0.0288 H-1->L+1 (16%),
HOMO->L+3 (79%)
10 3.8951 318.31 0.0036 H-4->LUMO (93%)
11 4.0002 309.94 0.0594 H-1->L+1 (70%),
HOMO->L+3 (-17%)
16 4.3527 284.85 0.487 H-5->LUMO (62%),
H-1->L+3 (-18%)
17 4.5666 271.5 0.0202 H-6->LUMO (92%)
18 4.5934 269.92 0.0152 HOMO->L+6 (73%)
19 4.6943 264.12 0.1168 H-7->LUMO (71%),
H-4->L+2 (14%)
20 4.8264 256.89 0.0107 H-6->L+2 (11%),
H-3->L+1 (-31%),
H-1->L+6 (32%)
21 4.8585 255.19 0.0691 H-7->LUMO (-16%),
H-4->L+2 (41%),
H-1->L+5 (-16%)
31 5.2475 236.27 0.0571 H-5->L+1 (55%),
H-1->L+4 (-15%)
32 5.2757 235.01 0523 H-6->L+2 (47%),
H-1->L+6 (-16%)
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Figure S4: Theoretical UV-vis spectrum of 2
S9
Table S9: Complex 2, selected singlet transitions
No. Energy (eV)  (nm) Osc. Strength Major contribs
1 2.6043 476.08 0.005 HOMO->LUMO (96%)
2 2.8917 428.77 0.0104 H-1->LUMO (-36%),
HOMO->L+1 (63%)
3 2.9879 414.95 0.0 HOMO->L+2 (90%)
4 3.091 401.12 0.1793 H-1->LUMO (57%),
HOMO->L+1 (35%)
5 3.1146 398.07 0.0029 H-2->LUMO (95%)
6 3.238 382.91 0.0346 H-1->L+1 (94%)
18 4.4342 279.61 0.0547 H-1->L+3 (86%)
20 4.5631 271.71 0.2794 H-7->LUMO (-31%),
H-6->LUMO (33%),
H-5->L+1 (13%)
21 4.6426 267.06 0.1963 H-6->L+1 (61%)
23 4.7911 258.78 0.0583 H-8->LUMO (38%),
H-4->L+2 (30%)
24 4.8089 257.82 0.0712 H-7->L+2 (-11%),
H-1->L+6 (51%)
25 4.8321 256.58 0.3062 H-7->LUMO (53%),
H-1->L+6 (10%)
26 4.8943 253.32 0.0108 H-8->LUMO (34%),
H-4->L+2 (-25%),
HOMO->L+4 (19%)
28 4.9633 249.8 0.0734 H-5->L+2 (-22%),
HOMO->L+4 (59%)
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Figure S5: Theoretical UV-vis spectrum of 3
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Table S10: Complex 3, selected singlet transitions
No. Energy (eV) (nm) Osc. Strength Major contribs
1 3.1223 397.09 0.0099A HOMO->LUMO (43%),
HOMO->L+1 (46%)
2 3.1654 391.68 0.0001 H-1->LUMO (40%),
H-1->L+1 (53%)
3 3.5748 346.83 0.0021 H-2->LUMO (37%),
H-2->L+1 (50%)
4 3.5777 346.55 0.0043 HOMO->LUMO (53%),
HOMO->L+1 (-45%)
5 3.7121 334.0 0.0005 HOMO->L+2 (87%)
7 3.8848 319.15 0.026 H-1->L+2 (98%)
11 4.3356 285.97 0.129 H-3->LUMO (25%),
H-3->L+1 (43%)
13 4.4197 280.52 0.0248 H-3->LUMO (50%),
H-3->L+1 (-16%),
HOMO->L+3 (31%)
18 4.7005 263.77 0.2771 H-4->LUMO (54%),
H-4->L+1 (-38%)
21 5.0252 246.73 0.0424 H-2->L+4 (96%)
23 5.0422 245.89 0.0614 H-8->LUMO (25%),
H-8->L+1 (27%)
26 5.2676 235.37 0.02 H-6->L+2 (-10%),
H-5->LUMO (-18%),
H-4->L+3 (51%),
29 5.3281 232.7 0.1156 HOMO->L+5 (68%)
31 5.4011 229.55 0.0156 H-5->LUMO (35%),
H-5->L+1 (52%)
32 5.4121 229.09 0.0011 H-7->LUMO (33%),
H-6->L+1 (26%),
H-1->L+5 (17%),
HOMO->L+6 (-11%)
S12
Figure S6: Orbital Energy Diagram for complexes 16.
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ADF Calculations
Table S11. Experimental and calculated absorption properties of 4
max, nm
 (M1
cm1)
Tra Composition Energy,eV (nm)
Oscillator
Strength
Assignment
350 25 HOMO9LUMO (91%)HOMO4 LUMO+2 (6%) 3.48(361) 0.0052 LLCT/LMCT
35
HOMO8LUMO (41%)
HOMO7LUMO (17%)
HOMO10LUMO (15%)
3.92 (316) 0.0746 LLCT/MLCT
40
HOMO10LUMO (38%)
HOMO8LUMO+1 (25%)
HOMO7LUMO+1
(25%)
4.10 (303) 0.0170
MLCT/LMCT
/LLCT
41
HOMO8LUMO+1 (64%)
HOMO10LUMO
(20%) 4.12 (301) 0.0266
MLCT/LMCT
/LLCT
304
(11402)
and
315
(9756)
42
HOMO9LUMO+1 (58%)
HOMO8LUMO+2 (23%) 4.17(297) 0.0165 LMCT/LLCT
43 HOMO1LUMO+5 (99%) 4.18(297) 0.0020 LLCT
44
HOMO7LUMO+2 (40%)
HOMO9LUMO+1 (29%)
HOMO8LUMO+2 (29%)
4.32 (297) 0.0025 LMCT/LLCT
45
HOMO4LUMO+1 (35%)
HOMO7LUMO+1 (14%)
HOMO6LUMO+2 (13%)
4.22 (294) 0.1730 LLCT/LMCT
46 HOMO7LUMO+3 (69%)
HOMO8LUMO+3 (31%)
4.24 (292) 0.0014 LLCT
47 HOMO9LUMO+3 (97%) 4.35 (285) 0.0027 LLCT
48
HOMO-7LUMO+4 (46%)
HOMO-8LUMO+4 (16%)
HOMO-5LUMO+1 (12%)
4.39 (282) 0.0979 LLCT/LMCT
250
(19102)
49 HOMO7LUMO+4 (25%)
HOMO5LUMO+1 (20%)
4.40 (282) 0.1697 LLCT/LMCT/
MLCT/
S14
HOMO6LUMO+1 (13%)
HOMO8LUMO+4 (13%)
MMCT
50 HOMO-9LUMO+4 (94%) 4.51 (275) 0.0098 LLCT
aTr = transition number as obtained in the TDDFT calculation output.
Figure S7: Complex 4, LUMO
S15
Figure S8: Complex 4, LUMO+1
Figure S9: Complex 4, LUMO+2
S16
Figure S10: Complex 4, HOMO
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